Symptomatic and functional outcome in youth at ultra-high risk for psychosis: A longitudinal study
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The current report assesses the clinical, functioning and demographic data of a cohort enrolled in the P3 prevention program for psychosis; a Spanish National Health System and Ministry of Science funded program. Comparisons are made between those individuals who had converted to psychosis and those who had not at 3years after an average of 24 treatment sessions. Subjects included 61 participants meeting Structured Interview for Prodromal Syndromes criteria, with ages ranging from 17 to 31, and all meeting criteria for ultra-high risk of psychosis. Prospective follow-up data are reported for patients re-evaluated at 1 and 3years. At 1-year follow-up, the conversion rate to psychosis was 18%, but increased to 23% at 3-year follow-up. The converted sample was older than the non-converted sample and more likely to have higher ratings on subsyndromal psychotic (positive and disorganized), negative and general symptoms, and lower levels of functioning at baseline assessment. Analyses of change over time indicated a clear clinical improvement in both clinically stable patients and in those who showed a transient psychotic state over time. No gender differences in symptom or functioning levels at the three follow-up time points were found; however, the interactions among conversionxgenderxSOPS total scorextime points significantly reflect that the growth profiles of the four groups (no conversion males, no conversion females, conversion males and conversion females) in the SOPS total score are not parallel and that, consequently, the four groups involved different patterns of change over time, males experiencing faster and longer deterioration when psychotic symptoms arise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Seidman, L. J., Perkins, D., Tsuang, M., McGlashan, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.3 · Cited by 1,269 · cited 5×
“Many variables have been found to be associated with risk of conversion to psychosis in previous studies, including genetic risk with recent deterioration of functioning, severity of prodromal symptoms, greater social impairment, and substance abuse (Cannon et al., 2008; Haroun et al., 2006; Yung et al., 2004, 2006).”
InfluentialMcGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., Germano, D., Bravin, J., McDonald, T., Blair, A., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.921 · Cited by 1,056 · cited 4×
“…(psychosocial and antipsychotics) or only with Cognitive Behavior Therapy (CBT), fall between 6% and 26% for the first year and around 26% after three years (Broome et al., 2005; Cornblatt et al., 2004; McGorry et al., 2002; Morrison et al., 2007; Nordentoft et al., 2006; Phillips et al., 2007).”
InfluentialMorrison, A. P., French, P., Walford, L., Lewis, S. W., Kilcommons, A., Green, J., Parker, S., & Bentall, R. P. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.4.291 · Cited by 740
Nordentoft, M., Thorup, A., Petersen, L., Øhlenschlæger, J., Melau, M., Christensen, T. Ø., Krarup, G., Jørgensen, P., & Jeppesen, P. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.01.002 · Cited by 178
Cited by
Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk
Fusar-Poli, P. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1472 · Cited by 1,361
EPA guidance on the early intervention in clinical high risk states of psychoses
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A., Nordentoft, M., Marshall, M., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.013 · Cited by 585
“3%) each from other European [5,24,48,53,58,92] and from Asian countries [40,45,52,56,57,134].”
BackgroundCognitive Deficits in Psychotic Disorders: A Lifespan Perspective
Sheffield, J. M., Karcher, N. R., & Barch, D. M. (2018) · Neuropsychology Review · doi:10.1007/s11065-018-9388-2 · Cited by 457
EPA guidance on the early detection of clinical high risk states of psychoses
Schultze-Lutter, F., Michel, C., Schmidt, S. J., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Nordentoft, M., Raballo, A., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.010 · Cited by 405
Outcomes of Nontransitioned Cases in a Sample at Ultra-High Risk for Psychosis
Lin, A., Wood, S. J., Nelson, B., Beavan, A., McGorry, P., & Yung, A. R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13030418 · Cited by 277
“At 2 years, attenuated symptoms have been evident in 35% (20) and 40% (19) of at-risk samples and in 25% (21) and 50% (22) at 3 years.”
BackgroundFusar-Poli, P., Rocchetti, M., Sardella, A., Avila, A., Brandizzi, M., Caverzasi, E., Politi, P., Ruhrmann, S., & McGuire, P. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.157115 · Cited by 272
Fusar-Poli, P., Yung, A. R., McGorry, P., & van Os, J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000184 · Cited by 218
“Previous studies have found that almost 12% of subjects presenting to a first assessment for HR symptoms were already psychotic, indicating that a substantial minority of individuals thought to be prodromal are in fact suffering a first episode of psychosis (Lemos-Giraldez et al. 2009).”
BackgroundRutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., Rocchetti, M., De Micheli, A., Jones, C., Palombini, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.053 · Cited by 138
“For example, recent studies have shown that a substantial proportion of the UHR patients up to 50% - continue suffering from APS over the follow-up period (Lee et al., 2014; Lemos-Giraldez et al., 2009; Velthorst et al., 2011), but the impact of affective anxiety or depressive disorders on APS persistence is underinve…”
BackgroundSimon, A. E., Borgwardt, S., Riecher-Rössler, A., Velthorst, E., de Haan, L., & Fusar-Poli, P. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.03.004 · Cited by 133
“As only one study included in our meta-analysis was a treatment study (Lemos-Giráldez et al., 2009) with a reported remission rate falling well within the range of the other studies, our meta-analysis is not suitable to further comment on the impact of intervention.”
Gender Differences in Individuals at High‐Risk of Psychosis: A Comprehensive Literature Review
Barajas, A., Ochoa, S., Obiols, J. E., & Lalucat-Jo, L. (2015) · The Scientific World Journal · doi:10.1155/2015/430735 · Cited by 122
“However, subsequently, mixed results have been obtained, from studies that contradict these results [18] as well as those that confirm them [25].”
BackgroundResultInfluentialSalazar de Pablo, G., Catalan, A., & Fusar-Poli, P. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3561 · Cited by 103
Effects of age and sex on clinical high-risk for psychosis in the community
Schultze-Lutter, F., Schimmelmann, B. G., Flückiger, R., & Michel, C. (2020) · World Journal of Psychiatry · doi:10.5498/wjp.v10.i5.101 · Cited by 34
Sex differences in symptomatology of psychosis-risk patients and in prediction of psychosis
Rosen, M., Haidl, T. K., Ruhrmann, S., Vogeley, K., & Schultze-Lutter, F. (2020) · Archives of Women's Mental Health · doi:10.1007/s00737-019-01000-3 · Cited by 16
Wilson, R. P., Patel, R., & Bhattacharyya, S. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12311 · Cited by 6
Metadata
- Authors
- Lemos-Giráldez, S., Vallina-Fernández, O., Fernández-Iglesias, P., Vallejo-Seco, G., Fonseca-Pedrero, E., Paíno-Piñeiro, M., Sierra-Baigrie, S., García-Pelayo, P., Pedrejón-Molino, C., Alonso-Bada, S., Gutiérrez-Pérez, A., & Ortega-Ferrández, J. A.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 115
- Issue
- 2-3
- Pages
- 121-129
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2102663315
- Cited by
- 87
- References
- 4
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.